Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China.

Zhang, Lei; Li, Yan-Ge; He, Shen; Zhang, Yan; Yu, Yi-Min; Li, Yan; Wen, Hui; Qiao, Ying; Shen, Yi-Feng; Li, Hua-Fang.
Acta Pharmacol Sin; 2019 Aug 06.
Artigo em Inglês | MEDLINE | ID: mdl-31388088

Documentos relacionados

  1. Zuclopenthixol dihydrochloride for schizophrenia.
  2. Aripiprazole versus other atypical antipsychotics for schizophrenia.
  3. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.
  4. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
  5. Acupuncture for schizophrenia.
  6. Zotepine versus other atypical antipsychotics for schizophrenia.
  7. Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling of risperidone and its active metabolite in Chinese schizophrenia patients.
  8. Aripiprazole versus other atypical antipsychotics for schizophrenia.
  9. Antipsychotic combinations for schizophrenia.
  10. Aripiprazole versus placebo for schizophrenia.